These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12187934)

  • 21. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.
    Elangbam CS; Tyler RD; Lightfoot RM
    Toxicol Pathol; 2001; 29(2):224-31. PubMed ID: 11421489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats.
    Zhang Q; Lian J; He M; Deng C; Wang H; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():172-80. PubMed ID: 24548587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
    Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
    Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
    Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
    Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of IL-15 on rat brown adipose tissue: uncoupling proteins and PPARs.
    Almendro V; Fuster G; Busquets S; Ametller E; Figueras M; Argilés JM; López-Soriano FJ
    Obesity (Silver Spring); 2008 Feb; 16(2):285-9. PubMed ID: 18239634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation and characterization in primary culture of white adipose tissue brown adipocyte-like cells.
    Lehr L; Canola K; Léger B; Giacobino JP
    Int J Obes (Lond); 2009 Jun; 33(6):680-6. PubMed ID: 19274054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist.
    Waites CR; Dominick MA; Sanderson TP; Schilling BE
    Toxicol Sci; 2007 Nov; 100(1):248-58. PubMed ID: 17675651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
    Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
    Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats.
    Desouza CV; Murthy SN; Diez J; Dunne B; Matta AS; Fonseca VA; McNamara DB
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):297-305. PubMed ID: 14740079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferative and molecular effects of the dual PPARalpha/gamma agonist tesaglitazar in rat adipose tissues: relevance for induction of fibrosarcoma.
    Glinghammar B; Berg AL; Bjurström S; Stockling K; Blomgren B; Westerberg R; Skånberg I; Hellmold H; Andersson U
    Toxicol Pathol; 2011 Feb; 39(2):325-36. PubMed ID: 21270424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?
    Starkey K; Heufelder A; Baker G; Joba W; Evans M; Davies S; Ludgate M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):55-9. PubMed ID: 12519830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet.
    Murthy SN; Obregon DF; Chattergoon NN; Fonseca NA; Mondal D; Dunne JB; Diez JG; Jeter JR; Kadowitz PJ; Agrawal KC; McNamara DB; Fonseca VA
    Metabolism; 2005 May; 54(5):645-52. PubMed ID: 15877295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures.
    Nisoli E; Clementi E; Tonello C; Sciorati C; Briscini L; Carruba MO
    Br J Pharmacol; 1998 Oct; 125(4):888-94. PubMed ID: 9831929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.
    Keshamouni VG; Reddy RC; Arenberg DA; Joel B; Thannickal VJ; Kalemkerian GP; Standiford TJ
    Oncogene; 2004 Jan; 23(1):100-8. PubMed ID: 14712215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ontogenic loss of brown adipose tissue sensitivity to beta-adrenergic stimulation in the ovine.
    Lomax MA; Sadiq F; Karamanlidis G; Karamitri A; Trayhurn P; Hazlerigg DG
    Endocrinology; 2007 Jan; 148(1):461-8. PubMed ID: 17023522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma.
    Houston KD; Copland JA; Broaddus RR; Gottardis MM; Fischer SM; Walker CL
    Cancer Res; 2003 Mar; 63(6):1221-7. PubMed ID: 12649180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.